246 related articles for article (PubMed ID: 18039638)
1. Oxidative stress and ferritin levels in haemodialysis patients.
Senol E; Ersoy A; Erdinc S; Sarandol E; Yurtkuran M
Nephrol Dial Transplant; 2008 Feb; 23(2):665-72. PubMed ID: 18039638
[TBL] [Abstract][Full Text] [Related]
2. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B
Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
[TBL] [Abstract][Full Text] [Related]
3. Effect of intravenous iron sucrose on oxidative stress in peritoneal dialysis patients.
Saglam F; Cavdar C; Uysal S; Cavdar Z; Camsari T
Ren Fail; 2007; 29(7):849-54. PubMed ID: 17994454
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis.
Elshamaa MF; Sabry S; Nabih M; Elghoroury EA; El-Saaid GS; Ismail AA
Ann Nutr Metab; 2009; 55(4):309-16. PubMed ID: 19828941
[TBL] [Abstract][Full Text] [Related]
5. Influence of oxidative stress and inflammation on rHuEPO requirements of hemodialysis patients with CRP values "in normal range".
Tutal E; Sezer S; Bilgic A; Aldemir D; Turkoglu S; Demirel O; Ozdemir N; Haberal M
Transplant Proc; 2007 Dec; 39(10):3035-40. PubMed ID: 18089316
[TBL] [Abstract][Full Text] [Related]
6. Long-term erythropoietin therapy does not affect metalloproteinases and their inhibitor levels, oxidative stress and inflammation in hemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Am J Nephrol; 2007; 27(3):221-5. PubMed ID: 17384500
[TBL] [Abstract][Full Text] [Related]
7. Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: a pilot study.
Anraku M; Kitamura K; Shintomo R; Takeuchi K; Ikeda H; Nagano J; Ko T; Mera K; Tomita K; Otagiri M
Clin Biochem; 2008 Oct; 41(14-15):1168-74. PubMed ID: 18692036
[TBL] [Abstract][Full Text] [Related]
8. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
Cavdar C; Temiz A; Yeniçerioğlu Y; Calişkan S; Celik A; Sifil A; Onvural B; Camsari T
Scand J Urol Nephrol; 2003; 37(1):77-82. PubMed ID: 12745750
[TBL] [Abstract][Full Text] [Related]
9. [Ferritin, oxidative stress and coronary atherosclerosis].
Kraml P; Potocková J; Koprivová H; Stípek S; Crkovská J; Zima T; Andĕl M
Vnitr Lek; 2004 Mar; 50(3):197-202. PubMed ID: 15125369
[TBL] [Abstract][Full Text] [Related]
10. Lipid peroxidative damage in the erythrocytes and elevation of serum LDL-cholesterol, apolipoprotein-B, ferritin and uric acid with age and in coronary heart disease patients.
El-Gebali HH; Tahir SA; Haider SS; El-Fakhri MM
Saudi Med J; 2000 Feb; 21(2):184-9. PubMed ID: 11533779
[TBL] [Abstract][Full Text] [Related]
11. Ferritin iron content in haemodialysis patients: comparison with septic and hemochromatosis patients.
Spada PL; Rossi C; Alimonti A; Bocca B; Cozza V; Ricerca BM; Bocci MG; Vulpio C; De Sole P
Clin Biochem; 2008 Aug; 41(12):997-1001. PubMed ID: 18541151
[TBL] [Abstract][Full Text] [Related]
12. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
13. [Effect of oxidative stress in patients with chronic renal failure].
González Rico M; Puchades MJ; García Ramón R; Saez G; Tormos MC; Miguel A
Nefrologia; 2006; 26(2):218-25. PubMed ID: 16808260
[TBL] [Abstract][Full Text] [Related]
14. Relationship between oxidative stress, ferritin and insulin resistance in sickle cell disease.
Alsultan AI; Seif MA; Amin TT; Naboli M; Alsuliman AM
Eur Rev Med Pharmacol Sci; 2010 Jun; 14(6):527-38. PubMed ID: 20712260
[TBL] [Abstract][Full Text] [Related]
15. Erythrocyte transmembrane electron transfer in haemodialysis patients.
Matteucci E; Cupisti A; Caprioli R; Battipaglia E; Favilla S; Rindi P; Barsotti G; Giampietro O
Nutr Metab Cardiovasc Dis; 2007 May; 17(4):288-93. PubMed ID: 17434051
[TBL] [Abstract][Full Text] [Related]
16. The plasma retinol levels as pro-oxidant/oxidant agents in haemodialysis patients.
Roehrs M; Valentini J; Bulcão R; Moreira JC; Biesalski H; Limberger RP; Grune T; Garcia SC
Nephrol Dial Transplant; 2009 Jul; 24(7):2212-8. PubMed ID: 19228758
[TBL] [Abstract][Full Text] [Related]
17. Sialic acid and oxidizability of lipid and proteins and antioxidant status in patients with coronary artery disease.
Serdar Z; Yeşilbursa D; Dirican M; Sarandöl E; Serdar A
Cell Biochem Funct; 2007; 25(6):655-64. PubMed ID: 17006879
[TBL] [Abstract][Full Text] [Related]
18. Effects of hemodialysis, dialyser type and iron infusion on oxidative stress in uremic patients.
Müller C; Eisenbrand G; Gradinger M; Rath T; Albert FW; Vienken J; Singh R; Farmer PB; Stockis JP; Janzowski C
Free Radic Res; 2004 Oct; 38(10):1093-100. PubMed ID: 15512797
[TBL] [Abstract][Full Text] [Related]
19. Elevated resistin is related to inflammation and residual renal function in haemodialysed patients.
Malyszko J; Malyszko JS; Kozminski P; Pawlak K; Mysliwiec M
Nephrology (Carlton); 2007 Jun; 12(3):246-53. PubMed ID: 17498119
[TBL] [Abstract][Full Text] [Related]
20. Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes.
Wu CC; Chen JS; Wu WM; Liao TN; Chu P; Lin SH; Chuang CH; Lin YF
Nephrol Dial Transplant; 2005 Jun; 20(6):1134-9. PubMed ID: 15814542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
